Associate Director, Commercial Data Investigation/Quality
Eisai US
Summary
The Associate Director, Commercial Data Investigation/Quality is responsible for ensuring pharmaceutical commercial data is accurate, complete, consistent, and fit for business consumption. This role requires strong knowledge of pharma commercial data combined with hands-on data analysis and investigation capabilities.
Job description
Essential Functions
- Apply strong knowledge of pharmaceutical commercial data to understand business rules, data relationships, expected data behavior, and downstream usage.
- Lead end-to-end investigation of data quality issues and perform root cause analysis across source data, integrations, transformations, master data, and downstream applications.
- Perform hands-on SQL querying, data profiling, reconciliation, trend analysis, and validation to identify and investigate data anomalies.
- Define and implement data quality rules and controls based on business requirements, critical data elements, known data patterns, and investigation findings.
- Establish monitoring for key data quality dimensions such as accuracy, completeness, consistency, validity, uniqueness, and timeliness.
- Partner with Commercial business teams, Data Management, Data Engineering, Analytics, IT, and external data providers to resolve data issues.
- Assess and prioritize data issues based on business and downstream impact.
- Drive issues through the full lifecycle from identification and root cause analysis through remediation, validation, and closure.
- Identify recurring issues and implement preventative controls rather than relying solely on reactive data fixes.
- Establish repeatable processes for data quality monitoring, investigation, escalation, remediation, and reporting.
- Communicate data quality findings, root causes, business impacts, and recommended solutions clearly to both business and technical stakeholders.
Requirements
- 8+ years of relevant experience in data management, data quality, commercial data operations, data analysis, or related disciplines, preferably within pharmaceutical or life sciences
- Strong understanding of pharmaceutical commercial data, preferably including HCP/HCO and affiliations, prescription and sales data, claims, specialty pharmacy/distributor data, market access, or other commercial datasets
- Demonstrated experience performing complex data investigations and root cause analysis across multiple systems and data sources
- Strong SQL and analytical skills, with the ability to independently query, profile, reconcile, and validate large datasets
- Hands-on experience defining and implementing data quality rules, controls, thresholds, and monitoring
- Working knowledge of databases, cloud data platforms, data warehouses/lakes, data pipelines, and downstream data consumption
- Ability to understand data lineage and trace issues from downstream consumption through transformations to their originating source
- Experience translating business expectations into measurable data quality requirements and controls
- Strong communication and cross-functional collaboration skills across business and technical teams
- Bachelor's degree in information technology, computer science, business analytics, engineering, or a related discipline
- Advanced degree is a plus
Benefits
- Annual Incentive Plan
- Long Term Incentive Plan
- Health Insurance
- Company Benefit Programs
Company overview
Eisai US is the American pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., a global pharmaceutical company founded in 1941. Headquartered in Nutley, New Jersey, Eisai US operates with a passionate commitment to patient care through its human health care (hhc) philosophy, which places patients and their families at the forefront of all business decisions. The company focuses on two primary therapeutic areas: oncology and neurology, with particular emphasis on dementia-related diseases and neurodegenerative disorders. Eisai US maintains a fully integrated pharmaceutical business model with end-to-end capabilities spanning discovery, development, and marketing. The organization operates commercial and clinical development organizations in New Jersey, discovery labs in Massachusetts and Pennsylvania, and global demand chain operations in Maryland and North Carolina. Notable products in its portfolio include Leqembi (lecanemab) for Alzheimer's disease, Lenvima (lenvatinib) for various cancers, and Aricept (donepezil) for Alzheimer's treatment. With approximately 1,001-5,000 employees in the United States, Eisai US represents a significant presence in the American pharmaceutical landscape, dedicated to addressing unmet medical needs through innovative therapies and comprehensive patient support programs.